MONDAY, Dec. 16, 2024 -- For patients with intermediate-risk breast cancer, chest wall irradiation (CWI) after mastectomy does not influence 10-year...

FRIDAY, Dec. 13, 2024 -- A “watch-and-wait” strategy might be the best option for some women with early-stage, low-risk breast...

The ZEST clinical trial, designed to evaluate niraparib (Zejula) for the prevention of breast cancer recurrence in patients with circulating tumor DNA...

A machine learning (ML) model incorporating both clinical and genomic factors outperformed models based solely on either clinical or genomic data in...

Patients with early-stage, node-negative, hormone receptor (HR)-positive, HER2- negative breast cancer who have a high risk of recurrence based on the...

The annual meeting of the Radiological Society of North America was held from Dec. 1 to 5 in Chicago, drawing participants from around the world,...

The annual meeting of the American Society of Hematology was held from Dec. 7 to 10 in San Diego and attracted participants from around the world,...

Cancer prevention and screening improvements have averted more deaths from five cancer types combined over the past 45 years than treatment advances,...

MONDAY, Dec. 16, 2024 -- Risk-reducing mastectomy (RRM) and salpingo-oophorectomy (RRSO) are both associated with significant improvements in outcomes...